Utah Medical Products (UTMD) Current Deferred Tax Assets (2010 - 2016)

Utah Medical Products' Current Deferred Tax Assets history runs 7 years deep, the most recent figure standing at $393000.0 for Q4 2016.

• On a quarterly basis, Current Deferred Tax Assets rose 8.26% year-over-year to $393000.0 in Q4 2016; TTM through Dec 2016 was $393000.0, a 8.26% increase from a year earlier, with the FY2016 full-year figure at $393000.0, up 8.26% from the prior year.
• Current Deferred Tax Assets improved to $393000.0 in Q4 2016 per UTMD's latest filing, from $363000.0 in the prior quarter.
• Across five years, Current Deferred Tax Assets topped out at $451000.0 in Q4 2012 and bottomed at $303000.0 in Q4 2014.
• The 5-year median for Current Deferred Tax Assets is $363000.0 (2015), against an average of $367600.0.
• Across the five-year window, Current Deferred Tax Assets jumped 35.44% in 2012 and retreated 27.27% in 2013, its largest moves.
• Year by year, Current Deferred Tax Assets stood at $451000.0 in 2012, then slipped by 27.27% to $328000.0 in 2013, then declined by 7.62% to $303000.0 in 2014, then climbed by 19.8% to $363000.0 in 2015, then rose by 8.26% to $393000.0 in 2016.
• Per Business Quant, the three latest UTMD Current Deferred Tax Assets figures stand at $393000.0 (Q4 2016), $363000.0 (Q4 2015), and $303000.0 (Q4 2014).